More from Dividend.com
Referenced Stocks

Robert Baird Cuts Amgen to “Neutral”; Recent Rally Overdone? (AMGN)

By Dividend.com September 12, 2012, 08:50:42 AM EDT

Biotech giant Amgen, Inc. ( AMGN ) on Wednesday caught a big downgrade from analysts at Robert W. Baird.

The firm cut its rating on AMGN from "Outperform" to "Neutral" while lowering its price target from $84 to $83. That new target suggests zero upside to the stock's Tuesday closing price of $83.94.

A Robert Baird analyst commented, "We agree AMGN's defensive nature, increased dividend and strong cash flow remain considerations for large-cap managers making cross-sector choices. However, from our vantage point, given the stock's +75% move since August 2011, this story appears to have largely played out for the near/intermediate term."

Amgen shares were mostly flat in premarket trading Wednesday.

The Bottom Line
Shares of Amgen ( AMGN ) have a 1.72% dividend yield, based on last night's closing stock price of $83.94. The stock has technical support in the $76-$80 price area. The shares are trading at all-time highs.

Amgen, Inc. ( AMGN ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: Investing, Stocks

Referenced Stocks: AMGN



Latest News Video






Most Active by Volume:

Company Last Sale Change Net / %
S $ 7 0.32  4.37%
PFE $ 29.10 0.30  1.02%
BAC $ 13.19 0.08  0.60%
MU $ 13.97 0.22  1.60%
SIRI $ 3.37 0.03  0.88%
GE $ 23.98 0.35  1.44%
QQQ $ 72.76 0.82  1.11%
ELN $ 14.15 0.37  2.69%